About AIM ImmunoTech (AIM)
AIM ImmunoTech Inc. is an immuno-pharmaceutical company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s flagship produc... Read more
- USD1.59
- USD1.60
- USD1.47
- USD36.00
- -40.20%
- 0M
- 38.68k
- 82.90k
- 4M
- 1.26
- -93.30%
Stock News
6 hours ago
Strategy’s stock shows why it’s a trade, and not an investment
MarketWatch
yesterday
Meta's Instagram orders employees back to the office 5 days a week
CNBC
yesterday
What Eli Lilly's move to cut prices on obesity drug Zepbound means for investors
CNBC
yesterday
What weak consumer? Strong holiday shopping kickoff is a good sign for retailers
CNBC